Call Options

19 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.46 - $0.63 $644 - $882
-1,400 Reduced 12.17%
10,100 $5,000
Q2 2022

Aug 15, 2022

BUY
$0.47 - $0.87 $5,405 - $10,005
11,500 New
11,500 $7,000
Q1 2022

May 16, 2022

SELL
$0.75 - $1.77 $15,525 - $36,639
-20,700 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.56 - $2.93 $9,984 - $18,752
-6,400 Reduced 23.62%
20,700 $34,000
Q3 2021

Nov 12, 2021

SELL
$2.91 - $4.83 $16,878 - $28,014
-5,800 Reduced 17.63%
27,100 $84,000
Q2 2021

Aug 06, 2021

BUY
$4.17 - $5.74 $82,566 - $113,652
19,800 Added 151.15%
32,900 $155,000
Q1 2021

May 14, 2021

SELL
$5.28 - $9.64 $7,392 - $13,496
-1,400 Reduced 9.66%
13,100 $69,000
Q4 2020

Feb 12, 2021

BUY
$5.75 - $7.13 $14,375 - $17,825
2,500 Added 20.83%
14,500 $92,000
Q3 2020

Nov 13, 2020

BUY
$4.9 - $7.12 $8,820 - $12,816
1,800 Added 17.65%
12,000 $71,000
Q2 2020

Aug 13, 2020

SELL
$6.43 - $9.86 $82,947 - $127,193
-12,900 Reduced 55.84%
10,200 $72,000
Q1 2020

May 11, 2020

SELL
$6.36 - $10.05 $260,124 - $411,045
-40,900 Reduced 63.91%
23,100 $174,000
Q4 2019

Feb 12, 2020

BUY
$8.49 - $12.81 $543,360 - $819,840
64,000 New
64,000 $544,000
Q3 2019

Nov 14, 2019

SELL
$5.58 - $14.47 $145,638 - $377,667
-26,100 Closed
0 $0
Q2 2019

Aug 20, 2019

SELL
$5.22 - $9.08 $62,640 - $108,960
-12,000 Reduced 31.5%
26,100 $158,000
Q1 2019

May 15, 2019

BUY
$5.35 - $9.82 $51,895 - $95,254
9,700 Added 34.15%
38,100 $300,000
Q4 2018

Feb 14, 2019

SELL
$3.43 - $6.19 $65,170 - $117,610
-19,000 Reduced 40.08%
28,400 $145,000
Q3 2018

Nov 14, 2018

BUY
$4.75 - $14.5 $113,525 - $346,550
23,900 Added 101.7%
47,400 $225,000
Q1 2018

May 15, 2018

SELL
$14.7 - $24.95 $263,130 - $446,605
-17,900 Reduced 43.24%
23,500 $377,000
Q4 2017

Feb 14, 2018

BUY
$19.9 - $29.25 $823,859 - $1.21 Million
41,400
41,400 $960,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.